6,6′,7,7′-Tetrakis(2-methoxyethoxy)-4H-[3,4′-biquinazolin]-4-one

Status: In-stock

6,6′,7,7′-Tetrakis(2-methoxyethoxy)-4H-[3,4′-biquinazolin]-4-one is an impurity of Erlotinib is used to treat certain types of non-small cell lung cancer that has spread to nearby tissues or other parts of the body in patients who have already been treated with at least one other chemotherapy medication. Erlotinib is in a class of medications called kinase inhibitors.

Request quotation

Additional information on 6 | 6' | 7 | 7'-Tetrakis(2-methoxyethoxy)-4H-[3 | 4'-biquinazolin]-4-one

Catalogue No. VE008800
CAS No. N/A
Molecular Formula C28H34N4O9
Molecular Weight 570.59 g/mol
Parent drug Erlotinib
IUPAC Name 6, 6', 7, 7'-Tetrakis(2-methoxyethoxy)-4H-[3, 4'-biquinazolin]-4-one
Synonyms N/A
References “Erlotinib: MedlinePlus Drug Information.” Medlineplus.gov, 2017, medlineplus.gov/druginfo/meds/a605008.html.
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

6,6′,7,7′-Tetrakis(2-methoxyethoxy)-4H-[3,4′-biquinazolin]-4-one

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden
This field is for validation purposes and should be left unchanged.